These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35220925)

  • 21. Identification of bioactive molecule from
    Tripathi MK; Singh P; Sharma S; Singh TP; Ethayathulla AS; Kaur P
    J Biomol Struct Dyn; 2021 Sep; 39(15):5668-5681. PubMed ID: 32643552
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Alagarsamy V; Solomon VR; Murugesan S; Sundar PS; Muzaffar-Ur-Rehman MD; Chandu A; Aishwarya AD; Narendhar B; Sulthana MT; Ravikumar V
    Curr Drug Discov Technol; 2024; 21(3):73-89. PubMed ID: 37861016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.
    Basit A; Ali T; Rehman SU
    J Biomol Struct Dyn; 2021 Jul; 39(10):3605-3614. PubMed ID: 32396773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virtual Screening of
    Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of the bioflavonoids with five SARS-CoV-2 proteins targets: An in silico study.
    Mishra GP; Bhadane RN; Panigrahi D; Amawi HA; Asbhy CR; Tiwari AK
    Comput Biol Med; 2021 Jul; 134():104464. PubMed ID: 34020130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
    Jafary F; Jafari S; Ganjalikhany MR
    Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 M
    Bharadwaj S; Azhar EI; Kamal MA; Bajrai LH; Dubey A; Jha K; Yadava U; Kang SG; Dwivedi VD
    J Biomol Struct Dyn; 2022 Apr; 40(6):2769-2784. PubMed ID: 33150855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational screening of natural products to identify potential inhibitors for human neuropilin-1 (NRP1) receptor to abrogate the binding of SARS-CoV-2 and host cell.
    Karkashan A; Attar R
    J Biomol Struct Dyn; 2023 Nov; 41(19):9987-9996. PubMed ID: 36437796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M
    Purohit P; Dash JJ; Muya JT; Meher BR
    J Biomol Struct Dyn; 2023 Jun; 41(9):3900-3913. PubMed ID: 35388744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M
    Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA
    J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Kaempferol as Viral Entry Inhibitor and DL-Arginine as Viral Replication Inhibitor from Selected Plants of Indian Traditional Medicine against COVID-19: An
    Jayaprakashkamath A; Murali M; Nair B; Benny F; Mani RP; Suresh D; Presanna AT; Areekkara AN; Nath LR
    Curr Comput Aided Drug Des; 2023; 19(4):313-323. PubMed ID: 36635906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach.
    Mathew SM; Benslimane F; Althani AA; Yassine HM
    Qatar Med J; 2021; 2021(1):12. PubMed ID: 34604010
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.
    Gollapalli P; B S S; Rimac H; Patil P; Nalilu SK; Kandagalla S; Shetty P
    J Biomol Struct Dyn; 2022 Apr; 40(6):2701-2714. PubMed ID: 33146070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An
    Behera SK; Mahapatra N; Tripathy CS; Pati S
    Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):132-143. PubMed ID: 33818470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining sialic acid derivatives as potential inhibitors of SARS-CoV-2 spike protein receptor binding domain.
    Banerjee T; Gosai A; Yousefi N; Garibay OO; Seal S; Balasubramanian G
    J Biomol Struct Dyn; 2024 Aug; 42(12):6342-6358. PubMed ID: 37424217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the binding affinity of andrographolide against human SARS-CoV-2 spike receptor-binding domain through docking and molecular dynamics simulations.
    Bhattarai A; Priyadharshini A; Emerson IA
    J Biomol Struct Dyn; 2023; 41(22):13438-13453. PubMed ID: 36764825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of potential inhibitor properties of violacein against HIV-1 RT and CoV-2 Spike RBD:ACE-2.
    Dogancı MA; Ay Sal F; Guler HI; Katı H; Ceylan E; Belduz AO; Bozdal G; Yaylı N; Canakcı S
    World J Microbiol Biotechnol; 2022 Jul; 38(9):161. PubMed ID: 35834025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition potential of natural flavonoids against selected omicron (B.1.19) mutations in the spike receptor binding domain of SARS-CoV-2: a molecular modeling approach.
    Kumar A; Dutt M; Dehury B; Sganzerla Martinez G; Swan CL; Kelvin AA; Richardson CD; Kelvin DJ
    J Biomol Struct Dyn; 2023 Dec; ():1-15. PubMed ID: 38115191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations.
    Ahamad S; Gupta D; Kumar V
    J Biomol Struct Dyn; 2022 Apr; 40(6):2430-2443. PubMed ID: 33140703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.